Cancers aggressive treatment. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Neoplastic Stem Cells Breast Prostate Tumor Cells, Cultured HCT116 Cells MCF-7 Cells HT29 Cells Lymph Nodes

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases60

Fournier Gangrene Prostatic Neoplasms Disease Progression Mediastinitis Neoplasm Recurrence, Local Breast Neoplasms Carcinoma, Squamous Cell Brain Neoplasms Arthritis, Rheumatoid Ovarian Neoplasms Lung Neoplasms Skin Neoplasms Recurrence Stomach Neoplasms Liver Neoplasms Colonic Neoplasms Hodgkin Disease Neoplasm Metastasis Neoplasm Invasiveness Pancreatic Neoplasms Neoplasms Lymphatic Metastasis Postoperative Complications Uterine Cervical Neoplasms Genetic Predisposition to Disease Acute Disease Carcinoma Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Hypertension Diabetes Mellitus, Type 2 Rectal Neoplasms Cell Transformation, Neoplastic Endometrial Neoplasms Esophageal Neoplasms Head and Neck Neoplasms Adenocarcinoma Mouth Neoplasms Neoplasms, Hormone-Dependent Carcinoma, Small Cell Neoplasms, Radiation-Induced Bone Neoplasms Neoplasms, Second Primary Neoplasms, Glandular and Epithelial Neovascularization, Pathologic Genital Neoplasms, Female Precancerous Conditions Gastrointestinal Neoplasms Thyroid Neoplasms Mammary Neoplasms, Experimental Pharyngeal Neoplasms Neoplasms, Multiple Primary Kidney Neoplasms Melanoma Neoplastic Syndromes, Hereditary Carcinoma, Lobular Breast Neoplasms, Male Disease Models, Animal Occupational Diseases

Chemicals and Drugs53

Antirheumatic Agents Antineoplastic Agents Tumor Markers, Biological Methotrexate Vincristine Cyclophosphamide Cancer Vaccines Neoplasm Proteins Doxorubicin Immunosuppressive Agents Anti-Bacterial Agents Receptors, Estrogen RNA, Messenger Receptor, erbB-2 Prostate-Specific Antigen DNA, Neoplasm RNA, Small Interfering Tumor Suppressor Protein p53 Fluorouracil Tamoxifen Cisplatin Receptors, Progesterone Antineoplastic Agents, Phytogenic Antineoplastic Agents, Hormonal Antigens, Neoplasm Anticarcinogenic Agents Paclitaxel Receptor, Epidermal Growth Factor MicroRNAs Tumor Suppressor Proteins Antibodies, Monoclonal Deoxycytidine Antimetabolites, Antineoplastic Receptors, Androgen Taxoids RNA, Neoplasm DNA-Binding Proteins BRCA2 Protein Androgens Proto-Oncogene Proteins Antibodies, Monoclonal, Humanized Transcription Factors BRCA1 Protein Carcinogens Nuclear Proteins Estrogens Proto-Oncogene Proteins c-akt Protein Kinase Inhibitors Estrogen Receptor alpha Quinazolines Androgen Antagonists Carcinoembryonic Antigen Organoplatinum Compounds

Analytical, Diagnostic and Therapeutic Techniques and Equipment71

Treatment Outcome Retrospective Studies Prognosis Fatal Outcome Combined Modality Therapy Debridement Follow-Up Studies Survival Rate Survival Analysis Early Detection of Cancer Prospective Studies Antineoplastic Combined Chemotherapy Protocols Neoplasm Staging Risk Factors Disease-Free Survival Risk Assessment Drug Therapy, Combination Tomography, X-Ray Computed Kaplan-Meier Estimate Severity of Illness Index Predictive Value of Tests Cohort Studies Multivariate Analysis Incidence Immunohistochemistry Magnetic Resonance Imaging Risk Reverse Transcriptase Polymerase Chain Reaction Gene Expression Profiling Registries Xenograft Model Antitumor Assays Proportional Hazards Models Neoplasm Transplantation Blotting, Western Odds Ratio Chemotherapy, Adjuvant Transplantation, Heterologous Sensitivity and Specificity Mammography Oligonucleotide Array Sequence Analysis Questionnaires Tumor Burden SEER Program Drug Screening Assays, Antitumor Molecular Targeted Therapy Clinical Trials as Topic Polymerase Chain Reaction Transfection Logistic Models Reproducibility of Results Radiotherapy Neoplasm Grading Tissue Array Analysis Confidence Intervals Models, Biological Gene Knockdown Techniques Flow Cytometry Mammary Neoplasms, Experimental Drug Administration Schedule Immunoenzyme Techniques Palliative Care Mastectomy Biopsy Immunotherapy Genetic Testing Radiotherapy, Adjuvant DNA Mutational Analysis Prostatectomy Colonoscopy Drug Delivery Systems Disease Models, Animal

Psychiatry and Psychology1

Phenomena and Processes45

Time Factors Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Drug Resistance, Neoplasm Risk Mutation Odds Ratio DNA Methylation Cell Survival Sensitivity and Specificity Genotype Cell Movement Genes, BRCA1 Down-Regulation Cell Division Polymorphism, Genetic Cell Cycle Dose-Response Relationship, Drug Cell Proliferation Cell Growth Processes Apoptosis Promoter Regions, Genetic RNA Interference Transfection Up-Regulation Gene Silencing Genes, Tumor Suppressor Germ-Line Mutation Genes, Neoplasm Genes, p53 Postmenopause Diet Genes, BRCA2 Base Sequence Gene Expression Phenotype Signal Transduction Phosphorylation Epithelial-Mesenchymal Transition Alleles Drug Synergism Tumor Microenvironment Epigenesis, Genetic Menopause Premenopause

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

Quality of Life National Cancer Institute (U.S.)Age Distribution

Humanities1

Quality of Life

Information Science8

Fatal Outcome Survival Rate Incidence Registries Questionnaires SEER Program Base Sequence Molecular Sequence Data

Named Groups3

Infant, Newborn Survivors European Continental Ancestry Group

Health Care35

Treatment Outcome Retrospective Studies Fatal Outcome Follow-Up Studies Survival Rate Survival Analysis Prospective Studies Risk Factors Age Factors Disease-Free Survival Risk Assessment Kaplan-Meier Estimate Severity of Illness Index Predictive Value of Tests Cohort Studies Multivariate Analysis Incidence Practice Guidelines as Topic Comorbidity National Cancer Institute (U.S.)Risk Registries Proportional Hazards Models Odds Ratio Sensitivity and Specificity Questionnaires SEER Program Clinical Trials as Topic American Cancer Society Logistic Models Reproducibility of Results Confidence Intervals Palliative Care Genetic Testing Age Distribution

Geographicals4

United States Japan China Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Treatment Outcome Retrospective Studies Prognosis Fatal Outcome Combined Modality Therapy Fournier Gangrene Prostatic Neoplasms Debridement Follow-Up Studies Disease Progression Survival Rate Survival Analysis Early Detection of Cancer Mediastinitis Antirheumatic Agents Prospective Studies Antineoplastic Combined Chemotherapy Protocols Neoplasm Staging Neoplasm Recurrence, Local Breast Neoplasms Risk Factors United States Age Factors Disease-Free Survival Risk Assessment Drug Therapy, Combination Antineoplastic Agents Carcinoma, Squamous Cell Brain Neoplasms Arthritis, Rheumatoid Time Factors Tumor Markers, Biological Tomography, X-Ray Computed Kaplan-Meier Estimate Ovarian Neoplasms Methotrexate Severity of Illness Index Lung Neoplasms Skin Neoplasms Predictive Value of Tests Recurrence Stomach Neoplasms Liver Neoplasms Colonic Neoplasms Vincristine Cohort Studies Hodgkin Disease Multivariate Analysis Incidence Neoplasm Metastasis Neoplasm Invasiveness Quality of Life Cyclophosphamide Pancreatic Neoplasms Neoplasms Gene Expression Regulation, Neoplastic Mice, Nude Cancer Vaccines Lymphatic Metastasis Immunohistochemistry Practice Guidelines as Topic Comorbidity Magnetic Resonance Imaging Postoperative Complications Neoplasm Proteins Uterine Cervical Neoplasms Doxorubicin Immunosuppressive Agents Genetic Predisposition to Disease Acute Disease Infant, Newborn Drug Resistance, Neoplasm Carcinoma Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung National Cancer Institute (U.S.)Risk Reverse Transcriptase Polymerase Chain Reaction Cell Line, Tumor Colorectal Neoplasms Anti-Bacterial Agents Receptors, Estrogen Gene Expression Profiling Registries Xenograft Model Antitumor Assays Proportional Hazards Models Hypertension Diabetes Mellitus, Type 2 Mutation RNA, Messenger Survivors Receptor, erbB-2 Rectal Neoplasms Neoplasm Transplantation Prostate-Specific Antigen DNA, Neoplasm Blotting, Western Cell Transformation, Neoplastic Endometrial Neoplasms Odds Ratio

No FAQ available that match "cancers aggressive treatment"